Ischemic Heart Disease Registry at Yokohama City University
Not Applicable
Recruiting
- Conditions
- Ischemic Heart Disease
- Registration Number
- JPRN-UMIN000041836
- Lead Sponsor
- Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Not provided
Exclusion Criteria
Rejection to the Registry.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prognosis including death, non-fatal myocardial infarction, non-fatal stroke, bleeding, revascularization, heart failure, and arrhythmias.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of atherosclerosis are being investigated in the YCU-IHD Registry for ischemic heart disease?
How does the YCU-IHD Registry compare outcomes of beta-blockers versus calcium channel blockers in ischemic heart disease patients?
Which biomarkers correlate with improved prognosis in STEMI or NSTEMI subtypes within the YCU-IHD Registry cohort?
What long-term adverse events are observed in YCU-IHD Registry participants receiving antiplatelet therapy for ischemic heart disease?
How does the YCU-IHD Registry data inform the role of PCSK9 inhibitors in combination with statins for atherosclerotic cardiovascular disease?